Turn Therapeutics Inc. Common Stock (TTRX) financials · $187.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Turn Therapeutics Inc. Common Stock (TTRX) $187.1M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$5.86M | -$1.80M |
| Net Income | -$3.19M | -$1.77M |
| EPS (Diluted) | N/A | N/A |
| Line | FY2025 |
|---|---|
| Total Assets | $12.2M |
| Current Assets | $5.20M |
| Cash & Equivalents | $4.03M |
| Total Liabilities | $7.48M |
| Current Liabilities | $6.00M |
| Shareholders' Equity | $4.69M |
| Retained Earnings | -$22.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$2.56M | -$1.36M |
| Investing Cash Flow | -$153.0K | -$99.5K |
| Financing Cash Flow | $6.92M | $1.15M |
FAQ
What is TTRX P/E and revenue?
Turn Therapeutics Inc. Common Stock (TTRX) $187.1M cap.
What is TTRX revenue?
TTRX income-statement cache has no revenue figure yet.
Is TTRX profitable?
Turn Therapeutics Inc. Common Stock last cached net income is -$3.19M (FY2025).
What are TTRX total assets?
Turn Therapeutics Inc. Common Stock last cached total assets are $12.2M (FY2025).
What is TTRX free cash flow?
No cached cash-flow row for TTRX yet.
Not investment advice. Cached statements, not a live tape.